Back

Incidence of pulmonary vein stenosis following atrial fibrillation ablation with standard-power long-duration, high-power and very high-power short-duration, and pulsed-field ablation

13 April 2026 (16:30 - 17:15)
Organised by: Logo
Congress Presentation Part of: Pulsed field ablation of atrial fibrillation: safety issues Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Yuka Oda

University of Tsukuba, Tsukuba (Japan)

7 More presentations in this session

Presentation thumbnail
High sensitivity Troponin-T after pulsed field ablation: associations with procedural characteristics and outcome
Mr J. Bruss (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Safety and acute efficacy of atrial fibrillation ablation using a pentaspline pulsed field ablation catheter in patients with severely reduced ejection fraction: results from the FRANCE-PFA registry
Doctor C. Chaumont (Rouen, FR)
Abstract Slides Video
Presentation thumbnail
Delayed diffuse coronary artery spasm following pulsed field ablation for atrial fibrillation: A case series review
Doctor J. Chiong (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Safety and feasibility of pulsed field ablation in patients with a prior left atrial appendage closure device
Doctor M. Marino (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Safety and device-device interactions of unipolar pulsed field ablation in patients with cardiac implantable electronic devices
Doctor A. Del Monte (Brussels, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Pulsed field ablation of atrial fibrillation: safety issues

The Event

Event poster

EHRA 2026

13 April 2026 16:30 CET
You may be interested in
thumbnail
Congress Presentation
Management of pulmonary vein stenosis
thumbnail
Congress Presentation
MRI investigations on the effects of pulsed field ablation via a 122-electrode spherical array catheter on pulmonary vein dimensions
thumbnail
Congress Session
Atrial fibrillation catheter ablation (2)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources